BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dev California Life Sciences - ECPv6.1.2.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://dev.califesciences.org
X-WR-CALDESC:Events for Dev California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220518T090000
DTEND;TZID=America/Los_Angeles:20220518T120000
DTSTAMP:20260407T092309
CREATED:20220419T200018Z
LAST-MODIFIED:20220420T163902Z
UID:8078-1652864400-1652875200@dev.califesciences.org
SUMMARY:IQVIA – Critical Success Factors For Commercialization Series – Asset Success Starts Early: Demonstrating and Communicating the Value of Your Therapy
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nAsset Success Starts Early: Demonstrating and Communicating the Value of Your Therapy \nIQVIA experts will share perspectives on how emerging biopharma companies can demonstrate and communicate the value of new therapies by engaging thought leaders to ensure their innovation reaches the patients who need it. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization-series-asset-success-starts-early-demonstrating-and-communicating-the-value-of-your-therapy/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220517T170000
DTEND;TZID=America/Los_Angeles:20220517T180000
DTSTAMP:20260407T092309
CREATED:20220427T180528Z
LAST-MODIFIED:20220427T180528Z
UID:8270-1652806800-1652810400@dev.califesciences.org
SUMMARY:2022 ACS CAN California Policy Roundtable and Awards Event
DESCRIPTION:The Registry is a comprehensive state-wide cancer surveillance program that collects information on cancers diagnosed in California and provides insight to develop strategies and policies for cancer prevention\, treatment\, and control to promote health equity among Californians living with cancer. \nWe will also honor State Senator Susan Rubio and Assemblymember Mike Gipson for championing legislation on behalf of cancer patients\, caregivers\, and their families. \nRegister»
URL:https://dev.califesciences.org/event/2022-acs-can-california-policy-roundtable-and-awards-event/
CATEGORIES:Industry Supported,Member Events
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220512T120000
DTEND;TZID=America/New_York:20220512T133000
DTSTAMP:20260407T092310
CREATED:20220408T183548Z
LAST-MODIFIED:20220414T212351Z
UID:7356-1652356800-1652362200@dev.califesciences.org
SUMMARY:Inclusive Research Mentor/Manager Course (TRAIN-UP) Spring 2022
DESCRIPTION:Location: Virtual \nThe University of California at San Francisco (UCSF) and City College of San Francisco (CCSF) are partnering with the CLS Racial & Social Equity Initiative to deliver a pilot aimed at helping life science organizations build inclusive management practices and work places. This training is designed to teach current and future industry professionals how to efficiently and effectively train\, performance manage\, and support interns and employees of diverse backgrounds in an effort to foster inclusive\, high-functioning working relationships. \nThis pilot is tailored for scientists who currently (or intend to) mentor and/or supervise in either academe or industry and is part of an NSF-funded initiative to build more inclusive lab environments. \nRegister» \n———- \nModule dates and descriptions:\nModule 1 – Are you ready to be an inclusive research mentor/manager? How good people unintentionally build inequitable work environments \n\nThursday May 12\, 2022 at 12 – 1:30 p.m.\nMany scientists have the best of intentions\, but lack clearly articulated benchmarks with which to evaluate their preparedness to be inclusive as a research mentor/manager. In this session\, participants will use frameworks to self-evaluate their current knowledge and skill level\, discuss barriers (including previous personal lab experience\, etc.)\, identify resources and strategies to further develop their skills\, and consider language to frame and discuss their abilities as an inclusive research mentor/manager.\n\nModule 2 – Effectively supervising people who aren’t you: Managing different workstyles \n\nTuesday May 17\, 2022 at 12 p.m. – 1:30 p.m.\nIn this module\, participants consider how individual differences in values\, approaches and relationship to work can impact productivity\, morale and retention of team members. We also discuss tangible steps that managers can take to intentionally cultivate inclusive environments. We consider several factors that may make up our individual ‘operating systems’ when we engage in work\, including how we prefer to communicate\, make decisions\, feel organized\, and manage change/conflict. Participants will also have the opportunity to assess some facets of their own work style preferences\, as well as develop the vocabulary to discuss others’ preferences without pathologizing their approach to work. Finally\, we discuss and brainstorm tactics that team leaders can use to inclusively manage multiple work style differences and reap the benefits of working in diverse teams.\n\nModule 3 – How to transparently set (performance and conduct) expectations \n\nThursday May 19\, 2022 at 12 p.m. – 1:30 p.m.\nGallup’s national State of the American Worker poll notes that half of all workers do not know what is expected of them. We discuss the challenges – the impossibility\, actually – of setting all performance and behavioral expectations at the beginning of someone’s tenure\, and the strategies that successful research mentors/managers use to set and manage those expectations over time. Participants will 1) identify which key expectations need to be set immediately to preserve their own productivity\, 2) define and articulate expectations to team members\, 3) overcome common challenges in setting expectations\, including when mentoring/supervising individuals who are more experienced than themselves or have a strongly held ‘operating system’/way of doing things\, and 4) consider criteria to determine if they’ve set an expectation effectively.\n\nModule 4 – Teach/train and delegate: Using best practices to train your diverse team \n\nTuesday May 24\, 2022 at 12 p.m. – 1:30 p.m.\nUsing effective training practices is important in any organization\, but it is particularly important in research organizations. In biotechnology companies\, the constant evolution of knowledge requires a solid training process to stay up to speed on innovative technology and knowledge. In this module\, we discuss common training issues that can result in loss of productivity for individuals and their teams\, and can put team members from some underrepresented groups at a disadvantage. We propose evidence-based approaches to avoid\, detect and correct these training issues.\n\nModule 5 – Communicating inclusively: developing your own feedback strategy and style \n\nThursday May 26\, 2022 at 12 p.m. – 1:30 p.m.\nDo you feel most comfortable offering positive (or kudos) feedback? Do you tend to avoid or sugarcoat corrective feedback? Not sure what ‘evaluative’ feedback is? Then this is the session for you. In this module\, we begin by dissecting the three types of feedback that everyone (including you) needs to be productive: kudos\, corrective and evaluative feedback. Participants will practice giving feedback using a protocol that works for both kudos and corrective feedback Next\, participants will modify the protocol as they consider their style (including their personal values\, approach and language). We’ll discuss strategies to both gain buy-in/determine how the recipient can best hear and act on that feedback\, and how to engage when the recipient has a strong reaction to feedback.\n\nModule 6 – When someone isn’t meeting your expectations: Strategies and resources to manage performance equitably \n\nTuesday May 31\, 2022 at 12 p.m. – 1:30 p.m.\nWhen someone repeatedly fails to meet performance or conduct expectations\, many research mentors/managers frequently under- or over-correct and mistakenly attempt to handle the situation alone (rather than reaching out for support). In this session\, participants will learn tactics to determine how their particular organization expects them to manage performance or conduct issues\, how to access organizational resources to help them navigate the situation (including HR\, Learning and Development\, etc.)\, and common mistakes and approaches (including building a circle of support/self care) to manage one of the most challenging responsibilities for any mentor/manager.\n\nModule 7 – How to inclusively hire: Which strategies will you use? \n\nThursday June 2\, 2022 at 12 p.m. – 1:30 p.m.\nIn this workshop\, participants will learn evidence-based strategies to assess and select candidates using tactics from four inclusive strategy clusters: 1) adding intentional respect\, 2) adding diverse voices\, 3) adding accountability) and 4) leveling the playing field. Participants will learn how to transparently structure the overall hiring process\, begin to develop their own questions/rubrics to assess for their priority qualifications\, consider steps to prepare and manage a hiring committee\, and discover tactics to mitigate others – and their own – unconscious biases.\n\nFormat: \n\nLive virtual workshops with individual and group work\nFull course OR individual workshops: Earn a Letter of Completion for the whole course or just take the sessions that you want.\n\nFacilitators: \n\nNaledi Saul\, Director\, UCSF Office of Career and Professional Development and Interim Chief of Staff (SAA/Graduate Division)/PI for the NSF ATE collaborative grant: A Collaborative Approach to Work-Based Learning in Biotechnology: Building Inclusive Lab Environments.(DUE #2055735)\nKaren Leung\, Biotechnology Faculty\, City College of San Francisco/PI for the NSF ATE collaborative grant: A Collaborative Approach to Work-Based Learning in Biotechnology: Building Inclusive Lab Environments.(DUE #2055309)
URL:https://dev.califesciences.org/event/cls-inclusive-mentor-manager-training-pilot/2022-05-12/
LOCATION:Virtual
CATEGORIES:Professional Development
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/04/CCSF_UCSF-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220512T090000
DTEND;TZID=America/Los_Angeles:20220512T100000
DTSTAMP:20260407T092310
CREATED:20220419T195644Z
LAST-MODIFIED:20220420T154527Z
UID:8076-1652346000-1652349600@dev.califesciences.org
SUMMARY:IQVIA - Critical Success Factors For Commercialization Series - Preparing to Enter the Market: A Focus on Market Access
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nPreparing to Enter the Market: A Focus on Market Access \nAsset success relies on strong engagement with the key stakeholders who will influence the path to the patient. Learn from IQVIA experts as they share key considerations for emerging biopharma companies who need to establish market access in the U.S. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization-series-preparing-to-enter-the-market-a-focus-on-market-access/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220512T080000
DTEND;TZID=America/New_York:20220512T123000
DTSTAMP:20260407T092310
CREATED:20220510T204604Z
LAST-MODIFIED:20220510T212253Z
UID:8548-1652342400-1652358600@dev.califesciences.org
SUMMARY:BISNOW - Norcal Life Sciences The Founding Life Science Hub: Research To Biotechnology\, Space Innovations\, And Future Expansions
DESCRIPTION:WHY THIS MATTERS\nWhat You’ll Learn:  \n\nWhat does the NorCal life sciences development pipeline look like for the rest of 2022? Including conversations across multi-building campuses\, towers\, and more!\nIn the hunt for space\, where is repurposing taking place and across which asset classes? Has speculative development taken over to achieve faster to market or do projects require certain specifications to remain attractive and competitive?\nWhat are the high-level tenant demands and are there the emerging trends that will continue throughout the year into the future of Life Sciences development?\nHow is Nothern California staying competitive with the East Coast and booming central markets\, like Houston? Across talent\, space\, and investment attraction what can be done to maintain and elevate the area’s global presence as a leading life science hub?\nWhere are investments coming from and what sectors are flooding with capital? Where does the opportunity lie and what lessons have been learned throughout the pandemic?\n\nRegister» \nHow You’ll Do More Business:  \nAs developers\, investors and owners spend billions to expand their life sciences portfolios\, Northern California has remained one of the leading hubs for the asset class across the nation. Absorption has seen record highs as millions of square feet are developed in Northern California alone\, and conversations about zoning\, repositioning\, and expansion rise with the need for space. As we rejoin in person\, let’s discuss how together we can capitalize on this booming industry\, do more business\, and advance this industry. \n  \nWho Attends:  \nOwners\, developers\, investors\, brokers\, city and government officials\, business consultants\, architects\, engineers\, lawyers\, accountants\, bankers\, technology companies\, and more! \n  \nWhy You Should Attend: \nBisnow events bring together the biggest power players in the industry to identify opportunities\, build your network and expand your business. With the largest audience of commercial real estate professionals in the world\, no one knows how to help your business more than us. Join Bisnow as we jump into the market in Northern California to analyze its strengths and strategize on its areas of opportunity. \n  \nGroup Ticket Discounts: Are you looking to buy 5 or more tickets? Fill out the form here to connect with Bisnow’s marketing team and get exclusive group discounts. \n  \nFor questions\, recommendations\, comments\, or press inquiries please email our California event producer\, Amani Navarrette at Amani.Navarrette@bisnow.com.
URL:https://dev.califesciences.org/event/bisnow-norcal-life-sciences-the-founding-life-science-hub-research-to-biotechnology-space-innovations-and-future-expansions/
LOCATION:JW Marriott San Francisco Union Square\, 515 Mason Street\, San Francisco\, CA\, 94102\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220511T173000
DTEND;TZID=America/New_York:20220511T193000
DTSTAMP:20260407T092310
CREATED:20220222T194723Z
LAST-MODIFIED:20220504T192242Z
UID:6544-1652290200-1652297400@dev.califesciences.org
SUMMARY:Spring Visionary Awards Reception
DESCRIPTION:Location: Washington DC \nPlease join us in welcoming California’s congressional delegation and industry stakeholders for an evening of networking and celebration. CLS will honor select federal legislators with our annual awards in recognition of their leadership in advancing federal policies to promote life sciences research\, investment\, and innovation. \nCongratulations to our 2022 awardees \n \nCalifornia Life Sciences members receive complimentary admission. This event is closed to service provider companies that are not members of California Life Sciences. To become a member\, click here.  \nRegister» \nThank you to our sponsors: \n \n  \nSponsorship opportunities are available\, please contact Emily Morgan\, Programs Director\, at emorgan@califesciences.org for more information. 
URL:https://dev.califesciences.org/event/spring-visionary-awards-reception/
LOCATION:Charlie Palmer Steak\, Washington DC\, 101 Constitution Ave. NW\, Washington\, DC\, 20001\, United States
CATEGORIES:Advocacy & Government Relations,Industry Collaboration & Networking
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/260032_CLS_22_Spring_Event-720x406-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220511T090000
DTEND;TZID=America/New_York:20220511T130000
DTSTAMP:20260407T092310
CREATED:20220325T193143Z
LAST-MODIFIED:20220420T155633Z
UID:7032-1652259600-1652274000@dev.califesciences.org
SUMMARY:Public Health & Its Access to Historically Excluded Communities\, Pt. 2 "Othering" People
DESCRIPTION:In jurisdictions as large and diverse as California\, the understanding of health equity and how to apply best practices could not be more pressing. Improving and assuring racial equity above racial equality has been shown to reduce inequity in healthcare outcomes through community-level investment\, equitable leadership development\, and most importantly increased access to timely and culturally responsive healthcare and treatment. Please join Ace Robinson\, California Life Sciences\, and Center for Excellence in Nonprofits for this four-part series exploring these topics. Participants will leave with a customized playbook on how to increase access and improve health outcomes for historically excluded communities. \nRegister»
URL:https://dev.califesciences.org/event/public-health-its-access-to-historically-excluded-communities/
LOCATION:Virtual
CATEGORIES:Industry Collaboration & Networking,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220511T090000
DTEND;TZID=America/Los_Angeles:20220511T100000
DTSTAMP:20260407T092310
CREATED:20220419T193126Z
LAST-MODIFIED:20220420T155241Z
UID:8070-1652259600-1652263200@dev.califesciences.org
SUMMARY:IQVIA - Critical Success Factors For Commercialization Series - Emerging Biopharma Prevailing Trends
DESCRIPTION:The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time\, more barriers to success are emerging with requirements for increasingly complex clinical trials\, continuous regulatory changes\, evolving payer conditions\, and more restrictive access to HCPs. \nIt’s evident that asset success starts early\, with a need to ensure evidence generation delivers endpoints that demonstrate value to regulators\, payers\, prescribers\, and patients. Communicating that value requires an adaptable\, omnichannel approach to activate and engage all stakeholders for launch and throughout the product lifecycle. \nLearn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them. \nIQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies. \nEmerging Biopharma Prevailing Trends \nHear key insights from the recently published IQVIA Institute report on the contribution of emerging biopharma to development and commercialization\, as well as prevailing commercial launch trends and the implications for a successful asset strategy. \nRegister» \nAsk the experts \nIQVIA experts will take your questions at the end of each session. If they are unable to address every question live\, they will follow up with an answer individually to ensure you have the information you need.
URL:https://dev.califesciences.org/event/iqvia-critical-success-factors-for-commercialization/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220505T170000
DTEND;TZID=America/New_York:20220505T190000
DTSTAMP:20260407T092310
CREATED:20220413T191217Z
LAST-MODIFIED:20220413T191246Z
UID:7540-1651770000-1651777200@dev.califesciences.org
SUMMARY:OUTbio Bay Area Kick Off & Networking Event
DESCRIPTION:Location: South San Francisco \n\n \n\nOUTbio Bay Area is the Bay Area’s first biotech industry’s LGBTQ+ professionals group. Our mission is to empower the LGBTQ+ community and its allies in biotechnology and affiliated industries. We are a new Bay Area chapter of the original non-profit OUTbio organization that was started in Boston in 2015 and has over 1\,200 members. Join us in supporting the LGBTQ+ professional community as we launch this exciting new chapter! \n\nRegister» \n\nAttend the kick-off event on May 5th to learn more about OUTbio Bay Area\, network with other LGBTQ+ professionals and allies in the biotech industry and find out how you can become involved with the group. \nHors d’oeuvres and refreshments will be served. Proof of COVID vaccination and booster required. Please have your vaccination card (or photo) with you at the event. \nRSVP by registering for the event. \nWe look forward to seeing you there! \n\n\nBy registering for this event\, you are automatically signing up for OUTbio Bay Area emails. Email outbiobayarea@gmail.com if you would like to be removed from the email listing. \nThank you to our sponsors! \n\n \n\n  \n  \n  \n 
URL:https://dev.califesciences.org/event/outbio-bay-area-kick-off-and-networking-event/
LOCATION:California Life Sciences\, The Lighthouse Cafe\, 685 Gateway Boulevard\, South San Francisco\, CA\, 94080
CATEGORIES:Industry Collaboration & Networking
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220504T100000
DTEND;TZID=America/Los_Angeles:20220504T110000
DTSTAMP:20260407T092310
CREATED:20220420T180350Z
LAST-MODIFIED:20220420T180450Z
UID:8097-1651658400-1651662000@dev.califesciences.org
SUMMARY:Copyright at Work
DESCRIPTION:If you’ve ever been puzzled by copyright questions\, don’t miss this opportunity to learn from the copyright experts and to expand your respect for intellectual property. Not only will you get answers to your copyright questions\, but you’ll also learn how to minimize your company’s exposure to illegal content use. Please join us for this engaging and educational webcast. \nThis session features: \n\nThe basics of copyright law\nWhat is and what is not copyright protected\nFair use – what it is and how it works\nWhen copyright permission is needed\, for both photocopies and electronic content\nHow to obtain copyright permission and much more…\n\nRegister»
URL:https://dev.califesciences.org/event/copyright-at-work/
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220504T090000
DTEND;TZID=America/Los_Angeles:20220505T153000
DTSTAMP:20260407T092310
CREATED:20220331T161046Z
LAST-MODIFIED:20220331T200751Z
UID:7075-1651654800-1651764600@dev.califesciences.org
SUMMARY:BioBasics 101: The Biology of Biotech for the Non-Scientist
DESCRIPTION:Location: South San Francisco \nBioBasics 101: The Biology of Biotech for the Non-Scientist is an intensive two-day course that explains the foundational science upon which all biopharma therapies are based. Day one focuses on the function of DNA\, RNA\, proteins\, and cell signaling and how each interacts in both healthy and diseased tissue. Day two builds on your newfound molecular biology knowledge. This includes a more in-depth look at genetic disease and how genetic engineering is used to create personalized medicine options for patients. The course ends with a survey of small molecule drugs\, biologics\, and vaccines and explains how each mitigates disease at the molecular level. BioBasics 101 will increase your scientific knowledge so that you can converse more effectively with colleagues\, clients\, regulators\, and scientists. \nDrug Development Immersion is a twelve-hour\, interactive course that explores the regulatory\, commercial\, and scientific factors that enable a drug to be successfully brought to market. Discussion features both small molecule drugs and biologics. Our instructors illustrate the corporate decision-making process with personal accounts\, giving participants unique insight into strategic development. Learn from an industry expert what it takes to get a molecule from the bench into the marketplace.\n  \nRegister»
URL:https://dev.califesciences.org/event/biobasics-101-the-biology-of-biotech-for-the-non-scientist/
LOCATION:685 Gateway Blvd\, Presentation Room\, South San Francisco\, CA\, 685 Gateway Blvd\, South San Francisco\, 94080
CATEGORIES:Professional Development
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/biotech-primer-image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220503T130000
DTEND;TZID=America/Los_Angeles:20220503T160000
DTSTAMP:20260407T092310
CREATED:20220427T163454Z
LAST-MODIFIED:20220427T180520Z
UID:8260-1651582800-1651593600@dev.califesciences.org
SUMMARY:USC - Grand Opening of Three Research Facilities At Michelson Center
DESCRIPTION:Grand Opening of Three Research Facilities @ USC Michelson Center\n\n\n\n\n\n\n\nDean Yannis Yortsos and Dean Amber Miller invite you to the Grand Opening of three state-of-the-art research facilities at the USC Michelson Center for Convergent Bioscience on Tuesday\, May 3rd\, 2022 from 1-4pm. \nHosted by: USC Viterbi School of Engineering and USC Dornsife College of Letters\, Arts and Sciences \nInterdisciplinary research conducted in these facilities is applicable to a variety of industries\, including biotech/biopharma\, aerospace\, advanced materials\, and semiconductor manufacturing. These core facilities enable a thriving research ecosystem; they are open to all members of the USC community and are available to external users. \nAgenda: \n\n1:00pm – Check-In\n1:30pm – Welcome by Deans of Viterbi & Dornsife\n1:45pm – Overview of the three facilities by Directors\n2:00pm – Graduate Research Poster Symposium\, Facility Tours\, and Reception\n\nRegister» \nHosted parking will be available for all guests
URL:https://dev.califesciences.org/event/usc-grand-opening-of-three-research-facilities-at-michelson-center/
LOCATION:USC Michelson Center for Convergent Bioscience\, 1002 Childs Way\, Los Angeles\, CA\, 90089\, United States
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220502T090000
DTEND;TZID=America/Los_Angeles:20220502T150000
DTSTAMP:20260407T092310
CREATED:20220225T011326Z
LAST-MODIFIED:20220331T204458Z
UID:6656-1651482000-1651503600@dev.califesciences.org
SUMMARY:Leadership EDGE for Women: Emotional Intelligence\, Session #7
DESCRIPTION:Location: Virtual \nThis is 7 of 7 stand-alone workshops designed to empower the women leaders in your organization to get the EDGE\, enabling them to excel within their companies\, develop their authentic leadership style\, gain support\, skills and tools\, and elevate their success. \nWhen it comes to professional and personal success\, emotional intelligence is as important as one’s intellectual ability. Develop an understanding of what emotional intelligence is and how it impacts business and leadership effectiveness\, discover personal strengths\, opportunities\, and roadblocks to demonstrating higher emotional intelligence\, and learn how to manage conflict as a means of building stronger relationships. \n  \nRegister»
URL:https://dev.califesciences.org/event/leadership-edge-for-women-emotional-intelligence-session-7/
LOCATION:Virtual
CATEGORIES:Professional Development
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics10.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220426T080000
DTEND;TZID=America/Los_Angeles:20220428T110000
DTSTAMP:20260407T092310
CREATED:20220415T170625Z
LAST-MODIFIED:20220420T152935Z
UID:7985-1650960000-1651143600@dev.califesciences.org
SUMMARY:WuXi Healthcare Forum 2022 - Call To Action
DESCRIPTION:We are delighted to share with you the full agenda below for the WuXi Healthcare Forum 2022\, taking place virtually on April 26-28. More than 50 distinguished global leaders will be speaking at this year’s forum\, where thousands of colleagues from around the world will unite once again under this year’s theme\, “Call To Action\,” to support the World Health Organization’s key initiatives in tackling global health challenges head-on\, and to collaboratively advance better healthcare solutions. \n  \n \n  \nComplimentary and open to the global healthcare innovation ecosystem\, this 3-day program will premiere via Zoom from 8am-11am PDT (11am-2pm EDT) daily from April 26-28. To accommodate our global audience\, all registrants will be provided with a link to the on-demand recording of this event. Please log on https://bit.ly/3ucMOgt to register this event and log on https://bit.ly/3jL4Oc5 for speaker bios and program updates. \n  \nAGENDA (The times below are AM\, Pacific Daylight Time | Virtual via Zoom) \n  \nDay 1\, April 26 \n8:00 Welcome & Opening Remarks \nHui Cai\, Program Chair\, VP & Head of Content\, WuXi AppTec Steve Yang\, Co-CEO\, WuXi AppTec \n8:10 Chronic Diseases: Rising to the Challenge A conversation between Sir Menelas Pangalos\, EVP & President\, BioPharmaceuticals R&D\, AstraZeneca\, and Steve Yang\, Co-CEO\, WuXi AppTec \n8:30 Global Health: From Partnership to Worldwide Access A conversation between Emilio Emini\, CEO\, Bill & Melinda Gates Medical Research Institute\, and Zina Affas Besse\, Deputy Head\, Healthcare Private Equity\, AXA Investment Managers Group \n8:50 Call to Action: The Neuro Challenge Walter Koroshetz\, Director\, National Institute of Neurological Disorders & Stroke\, National Institutes of Health \n9:10 Call to Action: The Cardiovascular Challenge A conversation between Mariell Jessup\, Chief Science & Medical Officer\, American Heart Association\, and Faiez Zannad\, Emeritus Professor of Therapeutics & Cardiology\, Université de Lorraine\, Inserm; Chairman\, CVCT\, Paris\, France \n9:35 Call to Action: The Cancer Challenge A conversation between Harold Burstein\, Institute Physician\, Dana-Farber Cancer Institute; Professor of Medicine\, Harvard Medical School\, Arif Kamal\, Chief Patient Officer\, American Cancer Society; Physician Quality & Outcomes Officer\, Duke Cancer Institute\, and Tony Mok\, Li Shu Fan Professor of Clinical Oncology\, The Chinese University of Hong Kong \n10:10 Spotlight on Antimicrobial Resistance Erin Duffy\, Chief of Research & Development\, CARB-X Valeria Gigante\, Team Lead\, AMR Division\, World Health Organization\, Geneva\, Switzerland Timothy Jinks\, Head of Infectious Diseases Interventions\, The Wellcome Trust Henry Skinner\, CEO\, AMR Action Fund Session Leader: Jenny Yip\, Managing Partner\, Adjuvant Capital \n11:00 Day 1 Adjourn \nDay 2\, April 27 \n8:00 Welcome & Opening Remarks \nRichard Soll\, Head of Boston Office & Senior Advisor of Strategic Projects\, WuXi AppTec Minzhang Chen\, Co-CEO\, WuXi AppTec \n8:10 Better. Faster. Smarter. \nStephen Hahn\, CEO-Partner\, Flagship Pioneering; CEO\, Harbinger Health \n8:30 Moving the Needle on Neurological Disorders Laurence Barker\, Partner\, The Dementia Discovery Fund Christina Isacson\, Partner\, Lightstone Ventures Philip Scheltens\, Head\, Dementia Fund\, EQT Life Sciences Session Leader: Rana Al-Hallaq\, Partner\, Pfizer Ventures \n9:05 Spotlight on Parkinson’s Disease \nA conversation between Todd Sherer\, EVP\, Research Strategy\, The Michael J. Fox Foundation for Parkinson’s Research\, and Andrew Siderowf\, Hurtig-Stern Professor in Neurology\, University of Pennsylvania Perelman School of Medicine \n9:30 Revitalizing Cardiovascular R&D \nSekar Kathiresan\, CEO\, Verve Therapeutics Michael Mendelsohn\, Founder & Chairman\, Cardurion Pharmaceuticals Christopher de Souza\, Director\, Broadview Ventures Claudia Ulbrich\, CEO & Co-Founder\, Cardior Pharmaceuticals Session Leader: Simone Fishburn\, VP & Editor in Chief\, BioCentury Inc. \n10:15 Reaching the Next Frontiers in Cancer Therapies Rajesh Chopra\, Venture Partner\, Head of Oncology\, Apple Tree Partners Adam Friedman\, President\, Corporate Strategy & Business Development\, Scorpion Therapeutics Luba Greenwood\, CEO\, Kojin Therapeutics KT Moortgat\, Healthcare Venture Investor\, Investment Partner\, Droia Ventures Lewis Williams\, Co-founder\, Chairman & CEO\, Walking Fish Therapeutics\, Inc. \nSession Leader: Dave Madge\, VP of Discovery Services\, WuXi AppTec \n11:00 Day 2 Adjourn \nDay 3\, April 28 \n8:00 Welcome & Opening Remarks \nJocelyne Bath\, Managing Director\, OXGENE Richard Connell\, SVP & US / EU COO\, WuXi AppTec \n8:10 Healthcare 2030: Current and Future Drivers of Success A conversation between William Hait\, EVP\, Chief External Innovation\, Medical Safety & Global Public Health Officer\, Johnson & Johnson\, and Julie Grant\, General Partner\, Canaan \n8:30 Spotlight on Singapore: The Asia-Pacific Translation Hub for Cell and Gene Therapy in Oncology Andrew Bruce\, CEO\, MediSix Therapeutics Wee Joo Chng\, Executive Director\, Singapore Translational Cancer Consortium; Director & Senior Consultant\, National University Cancer Institute\, Singapore\, NUHS Boon Tong Koh\, Executive Director\, Bioprocessing Technology Institute\, A*STAR\, Singapore Francesca Lim\, Assistant Medical Director\, Cell Therapy Facility\, Health Science Authority (HSA); Senior Consultant Hematologist\, Singapore General Hospital Yann Chong Tan\, Managing Director\, EVX Ventures; CEO\, Nuevocor; CSO\, Cargene Therapeutics Session Leader: Danny Soon\, CEO\, Consortium for Clinical Research & Innovation\, Singapore; Executive Director\, Singapore Clinical Research Institute \n9:30 Spotlight on UK: The Life Science Cluster Standing on the Shoulders of Giants Opening Remarks by Steve Bates\, CEO\, UK BioIndustry Association Billy Boyle\, Co-Founder & CEO\, Owlstone Medical Ryan Cawood\, CSO\, WuXi Advanced Therapies & OXGENE Kathryn Corzo\, COO\, bit.bio Jack O’Meara\, CEO\, Ochre Bio Session Leader: Michael Ward\, Global Head of Life Sciences & Healthcare Thought Leadership\, Clarivate \n10:30 When Technology Meets Healthcare \nVineeta Agarwala\, General Partner\, Andreessen Horowitz Rohit Chandra\, Chief Digital Officer\, Cleveland Clinic Daphne Koller\, CEO & Founder\, insitro Session Leader: Ben Robbins\, Venture Partner\, GV \n11:20 Forum Adjourn
URL:https://dev.califesciences.org/event/wuxi-healthcare-forum-2022/
LOCATION:Virtual
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220425
DTEND;VALUE=DATE:20220427
DTSTAMP:20260407T092310
CREATED:20220225T014326Z
LAST-MODIFIED:20220331T205755Z
UID:6669-1650844800-1651017599@dev.califesciences.org
SUMMARY:Stanford Drug Discovery Symposium (SDDS)
DESCRIPTION:Location: Virtual \n  \nAdvances in research and technology now afford us the unique opportunity to develop and test novel diagnostics and therapeutics. This conference takes advantage of the collective experience and expertise of our participants to cover a broad range of policy\, research\, and venture topics. This symposium provides an invaluable forum for interdisciplinary exchange at the forefront of drug research. \n  \nRegister»
URL:https://dev.califesciences.org/event/stanford-drug-discovery-symposium-sdds/
LOCATION:Virtual
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220421T083000
DTEND;TZID=America/Los_Angeles:20220421T153000
DTSTAMP:20260407T092310
CREATED:20220325T181939Z
LAST-MODIFIED:20220418T221747Z
UID:7021-1650529800-1650555000@dev.califesciences.org
SUMMARY:The Leadership EDGE: From the Laboratory to Leadership\, 4 days over 8 weeks
DESCRIPTION:Location: Virtual \n  \nCourse Dates: April 21\, May 4\, May 19\, and June 2 \nIt’s an incredibly exciting time for the life science industry. Today\, more than ever\, our clients have drug candidates entering late stages of development. We are celebrating the approvals of their innovative drugs and supporting them as they begin to commercialize these products in the market. The life science industry remains complex as access to capital continues to be challenging\, global partnering relationships are established\, and some companies adopt a virtual model. This fast-paced and ever-changing environment has provided us with an outstanding opportunity to redevelop our From the Laboratory to Leadership program\, building off of 32 years of success with over 7\,500 graduates from over 1000 life science companies. This fully redesigned program continues to turn science-minded first-time managers\, as well as managers seeking to expand their management skills\, into capable business leaders. We accomplish this by leveraging our extensive industry-specific knowledge and experience to utilize the most progressive and engaging professional development methods available. \nFrom the Laboratory to Leadership begins by helping participants assess who they are as leaders – their strengths\, styles\, and personal brand. From there\, we develop skills in the areas of communication\, priority management\, meeting management\, goal setting and planning\, delegation\, performance management\, and leading teams in a dynamic workplace. We wrap up the program in a fashion that brings all the learning together in a fun and impactful way. To drive high levels of engagement and impact\, this program integrates learning pods\, utilizes technology to measure progress and support a variety of learning styles\, encourages participants to use their companies as learning labs\, and helps clients set goals that deliver measurable results. \nCourse Dates: April 21\, May 4\, May 19\, and June 2 \nRegister»
URL:https://dev.califesciences.org/event/from-the-laboratory-to-leadership-4-days-over-8-weeks/
LOCATION:Virtual
CATEGORIES:Professional Development
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-11.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220419T133000
DTEND;TZID=America/Los_Angeles:20220419T160000
DTSTAMP:20260407T092310
CREATED:20220418T165716Z
LAST-MODIFIED:20220419T164645Z
UID:8023-1650375000-1650384000@dev.califesciences.org
SUMMARY:UCLA TDG - So You Have A Great Idea What's Next?
DESCRIPTION:The UCLA Postdoctoral Association is delighted to announce together with the Danforth Advisors and the UCLA Technology Development Group this in person event “So You Have A Great Idea What’s Next?” \nApril Pyle PhD | UCLA Broad Stem Cell Center; Pyle Lab at UCLA & co-founder MyoGene Bio \nBarbara Alcaraz Silva PhD  – Silicon Valley Bank \nAndy Kadlec\, M.D.\, Ph.D.– Vida Ventures \nMatt Hallinan JD – Cooley \n  \nPDA-TDG-DAdv \nRegister»
URL:https://dev.califesciences.org/event/ucla-tdg-so-you-have-a-great-idea-whats-next/
LOCATION:UCLA\, Boyer Hall 611 Charles E Young Dr E\, Los Angeles\, CA\, 90095\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220413T170000
DTEND;TZID=America/Los_Angeles:20220413T190000
DTSTAMP:20260407T092310
CREATED:20220323T225105Z
LAST-MODIFIED:20220405T122621Z
UID:7003-1649869200-1649876400@dev.califesciences.org
SUMMARY:Bio in the Brewery
DESCRIPTION:Location: Ballast Point Miramar \n  \nJoin us for beer and snacks as we mingle with our San Diego life sciences colleagues!  \n  \n \nRegister»
URL:https://dev.califesciences.org/event/bio-in-the-brewery/
LOCATION:Ballast Point Miramar\, 9045 Carroll Way\, San Diego\, California\, 92121
CATEGORIES:Industry Collaboration & Networking
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/259589_CLS_Bio_Brewery_Web_Calendar_720x406.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220412
DTEND;VALUE=DATE:20220415
DTSTAMP:20260407T092310
CREATED:20220225T013713Z
LAST-MODIFIED:20220331T204806Z
UID:6665-1649721600-1649980799@dev.califesciences.org
SUMMARY:Informa: MD&M West
DESCRIPTION:Location: Anaheim Convention Center \n  \nMD&M West is the leading medical device technology and innovation event in the US\, attracting thousands of engineers\, founders and buyers each year in Anaheim\, California. MD&M West is part of IME West\, representing all facets of advanced manufacturing including medical plastics\, packaging\, automation\, prototyping and much more. The three-day expo features more than 1\,500 exhibiting companies plus many conference and networking opportunities. \n  \nRegister»
URL:https://dev.califesciences.org/event/mdm-west/
LOCATION:Anaheim Convention Center\, Anaheim\, CA\, United States
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-14.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220406T120000
DTEND;TZID=America/Los_Angeles:20220406T133000
DTSTAMP:20260407T092310
CREATED:20220318T182641Z
LAST-MODIFIED:20220331T204715Z
UID:6966-1649246400-1649251800@dev.califesciences.org
SUMMARY:USC - Translational Science in the Context of Entrepreneurship
DESCRIPTION:Location: USC Michelson Hall \n  \nTranslation is the process of converting results in basic research into results that directly benefit humans. But what can the path from lab to market look like? Join us on April 6th at the USC Michelson Hall for a live dialogue with experts who will share their translational research journey. \nRegister» \nSpeakers: \nAuriane Gamelin\, MBA Entrepreneurship and Finances\, Co-Founder and COO of OncoXome\, has held operational roles at Fortune 500 companies for over a decade. With this operational experience\, Ms. Gamelin decided to fully commit to advancing cancer research and started OncoXome with her father\, Erick. Auriane earned certifications in drug development processes from UC-Berkeley and completed a training program in clinical investigations at the FDA headquarters. \nDr. Erick Gamelin\, MD\, PhD\, Co-Founder\, CEO & CSO of OncoXome\, Dr. Gamelni is a senior executive in the pharmaceutical industry\, a former professor of oncology\, leader of a research lab\, and a globally renowned expert in oncogenomics and molecular pharmacology. He has dedicated thirty years to oncology\, conducting basic\, translational\, and clinical research both in academia (part of his post-doc at the NIH\, Therapeutic Branch) and in the pharmaceutical industry. While in academia\, Dr. Gamelin participated in bringing several drugs to market such as paclitaxel\, oxaliplatin and nab-paclitaxel. He is a co- inventor on eight international patents and has published more than 140 scientific articles in international peer-reviewed journals. \nValery Fokin\, Ph.D. Professor of Chemistry\, USC\, Valery V. Fokin received his Ph.D. degree in 1998 from the University of Southern California\, where he worked under the direction of Professor Nicos A. Petasis. He then joined the group of Nobel Prize Winner Professor K. Barry Sharpless at The Scripps Research Institute in La Jolla\, California as a postdoctoral fellow\, where he studied catalytic oxidations of olefins. In 2001\, he was appointed assistant\, and in 2006 associate professor in the Chemistry Department at Scripps. His research is centered on understanding of the chemical reactivity and its applications in chemistry\, biology\, and materials science. \nDr Bodhour Salhia Ph.D.\, USC\, Dr. Salhia is a translational genomics scientist with extensive knowledge and expertise in mechanisms that underlie tumorigenesis and tumor biology. She merges cutting edge genomics/epigenomics analyses with cell biological and functional studies towards the investigation of clinically relevant problems in human cancer. She has led and continues to lead numerous DNA methylation studies using a plethora of both array and sequencing based technologies to measure whole genome and targeted CpG methylation changes in a variety of cancer types. \nModerator: \nVasiliki Anest\,Ph.D USC\, Dr. Anest serves as the Chief Innovation Officer for USC Norris. She leads the development of innovation strategies and builds high‐value industry collaborations and strategic partnerships throughout USC and externally. Dr. Anest also serves as Senior Director of Business Development and Industry Relations at the MESH Academy and Business Director of the Rosalie and Harold Rae Brown Center for Cancer Drug Development at USC Norris. She has forged collaborative relationships and formulated unique partnering strategies with university\, government\, and industry partners.
URL:https://dev.califesciences.org/event/translational-science-in-the-context-of-entrepreneurship/
LOCATION:USC Michelson Hall\, 1002 Childs Way\, Los Angeles\, CA\, 90089\, United States
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220406T101500
DTEND;TZID=America/Los_Angeles:20220406T120000
DTSTAMP:20260407T092310
CREATED:20220218T180755Z
LAST-MODIFIED:20220331T204532Z
UID:6483-1649240100-1649246400@dev.califesciences.org
SUMMARY:Johnson & Johnson Innovation - The Search for Solutions to the Delivery Challenges of Nucleic Acid-Based Therapies
DESCRIPTION:Location: Virtual \n  \nGene and nucleic acid therapies are increasingly being established as important modalities for the next generation of medicine. However\, in vivo delivery challenges currently limit their full potential to achieve more widespread clinical use. Scientific innovations are needed to improve the efficiency\, tissue biodistribution\, cellular/ tissue selectivity\, payload capacity\, and immunogenicity to enable therapies with enhanced safety and efficacy profiles. \nIn this webinar\, our panel of scientific experts and entrepreneurs will highlight some of the key delivery challenges facing the field of gene and nucleic acid therapeutics and will discuss select scientific innovations that are being undertaken with the aim to address these challenges. Discussion topics will include both viral and non-viral systems for delivery of DNA\, mRNA\, siRNA/ASO payloads in addition to cell/tissue specific targeting approaches. \nDPDS (Discovery\, Product Development and Supply) of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen)’s external innovation team invites innovators with potential solutions to these challenges to apply for an opportunity to meet 1-on-1 to discuss their innovative solutions. \nAreas of particular interest include unmet needs in:\n– Enhanced delivery to retina\, cochlea\, brain\, kidney\, and heart\n– Cell targeting moieties for selective cellular uptake\n– Lipid nanoparticles with cell targeting properties\n– AAV capsid engineering for improved biodistribution\n– Approaches to limit immune surveillance and response \nRegister»
URL:https://dev.califesciences.org/event/the-search-for-solutions-to-the-delivery-challenges-of-nucleic-acid-based-therapies/
LOCATION:Virtual
CATEGORIES:Member Events
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics11.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220404T090000
DTEND;TZID=America/Los_Angeles:20220404T150000
DTSTAMP:20260407T092310
CREATED:20220225T010844Z
LAST-MODIFIED:20220331T210010Z
UID:6654-1649062800-1649084400@dev.califesciences.org
SUMMARY:Leadership EDGE for Women: Communication and Influence for Impact\, Session #6
DESCRIPTION:Location: Virtual \n  \nThis is 6 of 7 stand-alone workshops designed to empower the women leaders in your organization to get the EDGE\, enabling them to excel within their companies\, develop their authentic leadership style\, gain support\, skills and tools\, and elevate their success. \nEffective communication is key to persuasion\, motivation\, and information sharing. Learn how to successfully influence others\, reduce conflict\, and improve the performance of others by recognizing and respecting communication preferences; explore gender-specific communication strengths and opportunities; uncover obstacles that may prevent successful communication from occurring\, and develop a roadmap for improved communication and greater influence. \n  \nRegister»
URL:https://dev.califesciences.org/event/leadership-edge-for-women-communication-and-influence-for-impact-session-6/
LOCATION:Virtual
CATEGORIES:Professional Development
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-11.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220329T113000
DTEND;TZID=America/Los_Angeles:20220329T121500
DTSTAMP:20260407T092310
CREATED:20220301T004358Z
LAST-MODIFIED:20220301T212752Z
UID:6736-1648553400-1648556100@dev.califesciences.org
SUMMARY:National Life Science Startup Symposium - "FDA For Life Science Companies: The Insiders Guide to FDA Approval"
DESCRIPTION:Kwame Ulmer is a 12 year veteran of the FDA and currently works as a regulatory strategist and investor. You will learn how to develop a regulatory strategy\, maximize your interactions with the FDA and efficiently get your product approved. The presentation is geared towards helping C-Suite executives understand the key levers to drive premarket approval and compliance attractive to investors. The presentation will also discuss overcoming the regulatory challenges during COVID.
URL:https://dev.califesciences.org/event/national-life-science-startup-symposium-fda-for-life-science-companies-the-insiders-guide-to-fda-approval/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220329
DTEND;VALUE=DATE:20220401
DTSTAMP:20260407T092310
CREATED:20220219T000027Z
LAST-MODIFIED:20220331T204215Z
UID:6514-1648512000-1648771199@dev.califesciences.org
SUMMARY:Pismo Ventures: National Life Science Startup Symposium
DESCRIPTION:Location: Virtual \nWe are excited to announce the upcoming National Life Science Startup Symposium on March 29th and 31st. This is a Pismo Ventures Event\, sponsored and presented by The George Washington University and The Society of Physician Entrepreneurs. \nThe website event is: https://lifescience.startupsymposium.com and the Registration Deadline is March 13\, 2022. \nAs members of the organizing committee\, we would like to invite startups to participate in the Symposium. Startup participants have a tremendous opportunity to be seen by hundreds of investors across the country\, and have a chance of being funded by the participating investors.\nThis is our third Symposium. At the last two Symposiums\, we had over 200 startups participating. We also had (and will have for this Symposium) about 150+ Angel investors and 50+ VCs who judge the startup pitches. This dynamic provides tremendous value to both the startups and the investors. The startups get exposures to numerous potential investors\, and the investors get an excellent deal flow to evaluate. A few startups from our previous Symposiums got the attention of the judges/investors and received significant investments subsequently\, e.g. via SPV’s and/or direct angel/VC investments. \nIn addition to providing this opportunity to be seen by a large number of investors\, the Symposium includes the following valuable panels and webinars. \nPanels:\n“Working with University Tech Transfer for Startups”\n“Partnering with Big Pharma\, Diagnostic\, and MedTech Companies for Startups” \nWebinars:\n“Structuring your Startup and Negotiating Financing”\n“FDA For Life Science Companies: The Insiders Guide to FDA Approval” \nWe have already confirmed participation from the following organizations\, and are expecting many more: \n\nGeorge Washington University\nGeorgetown University\nArizona State University\nUniversity of Arizona\nUniversity of California Irvine\nUniversity of California Berkeley\n\nNote: FREE registration for all applicants. \nWe are sure that it will be a great event to increase visibility for startups and also provide them with valuable information and contacts. \nRegister»
URL:https://dev.califesciences.org/event/national-life-science-startup-symposium/
LOCATION:Virtual
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-13.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220325T080000
DTEND;TZID=America/Los_Angeles:20220325T090000
DTSTAMP:20260407T092310
CREATED:20220310T224234Z
LAST-MODIFIED:20220310T224337Z
UID:6894-1648195200-1648198800@dev.califesciences.org
SUMMARY:Halloran Town Hall: Total Data Control and Custody – Moving from Excel to Complete Integration for Better Clinical Trial Decisions
DESCRIPTION:We have certainly come a long way in clinical trial operations over the past few years as our industry collectively shifted to decentralized and hybrid models to collect patient data outside of the traditional site model. And sponsors have a lot of data. This growth\, though celebrated\, also comes with growing pains\, like figuring how to build a large data mapping infrastructure to harness the trial’s data for better insight and oversight. \nIf you’re experiencing a similar issue\, please join our Halloran-hosted virtual Town Hall on March 25\, 2022\, from 11:00a.m. – 12:00p.m. EST on “Total Data Control and Custody: Moving from Excel to Complete Integration for Better Clinical Trial Decisions” led by the global data strategy and innovation team at CSL Behring and joined by experts from Halloran. CSL Behring has recently designed a data infrastructure for their studies that allowed their teams to have better control over their data\, leading to more informed decisions. They have major lessons learned and context behind their change and will be sharing their insights with the panel (and you!) to work through the following: \nHow do you integrate data sources and automate processes to get to a point of total data control regardless of company size? \nHow to get executive buy-in around data standards and oversight? \nWhat does the planning entail? Where do we start? \nIs this the future of data? How should companies prepare? \nIf you too want to evolve in this direction\, there is significant time and money that will need to be spent well in advance of when the trial data needs to be submitted. So\, let’s brainstorm and learn from each other. We hope you can join us – and bring your questions – to talk through scenarios for better data strategy\, control\, and custody for better decision making. \nMeet the Panel: \nMeghan Powers\, Director\, Clinical Practice Operations\, Halloran Consulting Group; Karen Travers\, Associate Principal Consultant\, Organizational & Quality Solutions\, Halloran Consulting Group; Thomas Verish\, Head of Global Data Strategy & Innovation\, CSL Behring; Valerie Reynaert\, Head of Global Clinical Operations\, CSL Behring; Charles Johnson\, Director\, eClinical Operations\, CSL Behring; Tony Ciliberto\, Senior Director\, Global Clinical Operations\, CSL Behring \nRegister» \nUpon registration you will receive a calendar invite with Zoom info.
URL:https://dev.califesciences.org/event/halloran-town-hall-total-data-control-and-custody-moving-from-excel-to-complete-integration-for-better-clinical-trial-decisions/
LOCATION:Live\, Online
CATEGORIES:Industry Supported,Member Events
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-12.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220322T170000
DTEND;TZID=America/Los_Angeles:20220322T190000
DTSTAMP:20260407T092310
CREATED:20220222T192932Z
LAST-MODIFIED:20220321T221859Z
UID:6486-1647968400-1647975600@dev.califesciences.org
SUMMARY:Champions Reception
DESCRIPTION:Join California Life Sciences as we recognize and award our legislators of the year! \nThese life sciences champions supported and demonstrated tremendous leadership in advancing policies that enhance healthcare innovation and cures for California and the world. Now\, more than ever\, we want to thank and applaud lawmakers who stand with us as our companies respond to the global pandemic. \nJoin your colleagues and life sciences company executives on February 8 as we host a reception to honor state policymakers who support California’s world leading life sciences ecosystem! \n2021 Life Sciences Champions: \n\nAttendance at this event by a public official will constitute acceptance of a reportable gift. \nCalifornia Life Sciences members receive complimentary admission. This event is closed to service provider companies that are not members of California Life Sciences. To become a member\, click here. \nSponsorship opportunities are still available\, please contact Emily Morgan\, Programs Director\, at emorgan@califesciences.org for more information. \nThank You to Our 2022 Sponsors: \n \nRegister» \n 
URL:https://dev.califesciences.org/event/champions-reception/
LOCATION:Ella Dining Room & Bar\, 1131 K St\, Sacramento\, CA\, 95814\, United States
CATEGORIES:Advocacy & Government Relations,Industry Collaboration & Networking
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-5.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220319T100000
DTEND;TZID=America/Los_Angeles:20220319T170000
DTSTAMP:20260407T092310
CREATED:20220218T233230Z
LAST-MODIFIED:20220225T173409Z
UID:6508-1647684000-1647709200@dev.califesciences.org
SUMMARY:Quest Science Center: Tri-Valley Innovation Fair 2022
DESCRIPTION:Quest Science Center is excited to present an opportunity to connect everyone to the value of science at the 4th Annual Tri-Valley Innovation Fair 2022\, taking place from 10am-5pm on Saturday\, March 19\, 2022 at the Alameda County Fairgrounds. \nTri-Valley Innovation Fair 2022 will take science and learning to a new level\, transforming the Alameda County Fairgrounds into the venue that will showcase the best of Tri-Valley innovation in the fields of Science\, Technology\, Engineering and Math. \nDesigned to bring science and technology to life through fun and interactive activities\, exhibits and program sessions\, the fair will appeal to a diverse audience including families\, educators\, students and curious minds alike. The event will be open to the general public\, showcasing the Tri-Valley to the greater Bay Area – connecting the region’s innovation & education. \nExhibitor Registration is Now Open!\nHow is your business using science and technology to make our lives better? Are you an incubator for new ideas? Can you demonstrate how you’re using data analysis in innovation? Do your scientists or engineers enjoy inspiring students and families? How are you making technology accessible and safe for all? Are you on the brink of discovering the next software or hardware wave of the future? Are you an educator with an amazing class project? \nRegister»
URL:https://dev.califesciences.org/event/quest-science-center-tri-valley-innovation-fair-2022/
LOCATION:Alameda County Fairgrounds\, 4501 Pleasanton Avenue\, Pleasanton\, CA\, 94566\, United States
CATEGORIES:Industry Collaboration & Networking
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-15.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220317T170000
DTEND;TZID=America/Los_Angeles:20220317T190000
DTSTAMP:20260407T092310
CREATED:20220215T182407Z
LAST-MODIFIED:20220225T163523Z
UID:6400-1647536400-1647543600@dev.califesciences.org
SUMMARY:Bio on the Bay Happy Hour
DESCRIPTION:A bit of malarkey and lots of green beer\, make no mistake you’ll want to be here. Join CLS and Lonza for our annual Bio on the Bay\, an informal networking event for the life sciences community. \nThis event is closed to service provider companies that are not members of California Life Sciences. To become a member\, click here. \nTo ensure a safe and enjoyable experience for everyone\, please review our event safety protocols prior to the event. \nRegister»
URL:https://dev.califesciences.org/event/bio-on-the-bay-happy-hour/
LOCATION:The Lighthouse Cafe\, 685 Gateway Boulevard\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:Industry Collaboration & Networking
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220316T180000
DTEND;TZID=America/New_York:20220316T210000
DTSTAMP:20260407T092310
CREATED:20220215T181639Z
LAST-MODIFIED:20220224T210541Z
UID:6397-1647453600-1647464400@dev.califesciences.org
SUMMARY:Executive Dinner\, hosted by California Life Sciences\, Perkins Coie\, & Silicon Valley Bank
DESCRIPTION:California Life Sciences\, Perkins Coie\, and Silicon Valley Bank will host an intimate dinner amongst life sciences executives discussing SVB’s 2021 Healthcare Annual Report\, which analyzes and predicts trends for investing\, fundraising and exits that shape the biopharma\, medical device and diagnostics and healthtech sectors. \nCalifornia Life Sciences Executive Dinners are a custom dinner experience consisting of up to 20 life sciences leaders engaged in thought-provoking conversation around a specific topic that is neither a formal presentation nor solicitation. From digital health to women in leadership\, topics are carefully curated to align with your personal and/or organizational expertise. In collaboration with the sponsor\, CLS will manage attendee selection and invitations\, venue selection and on-site event details. If you’re interested in sponsoring our next executive dinner\, please contact Emily Morgan at emorgan@califesciences.org.  \nThank you to our dinner sponsor:
URL:https://dev.califesciences.org/event/executive-dinner-silicon-valley-bank-2021-healthcare-annual-report/
LOCATION:San Francisco\, San Francisco\, CA\, United States
CATEGORIES:Curated Events,Industry Collaboration & Networking
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/02/258762_CLS_22_Event_Graphics-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220316T110000
DTEND;TZID=America/Los_Angeles:20220316T113000
DTSTAMP:20260407T092310
CREATED:20220302T234427Z
LAST-MODIFIED:20220304T001319Z
UID:6766-1647428400-1647430200@dev.califesciences.org
SUMMARY:Using STEP and SciLeads To Grow Your California Biotech Business
DESCRIPTION:Join the live webinar with Laura Haldane as she introduces SciLeads\, an innovative life science and applied research lead generation platform. SciLeads works with bioscience companies in California and around the world to accelerate their sales by enabling them to quickly find and engage with targeted and funded leads\, and develop outreach strategies. \nAlso joining Laura is Mariana Guevara from the California Governor’s Office of Business and Economic Development who will speak about how the STEP grant program can contribute toward the cost of the SciLeads database subscription. \nRegister»
URL:https://dev.califesciences.org/event/using-step-and-scileads-to-grow-your-california-biotech-business/
LOCATION:Live\, Online
CATEGORIES:Industry Supported
ATTACH;FMTTYPE=image/jpeg:https://dev.califesciences.org/wp-content/uploads/2022/03/258762_CLS_22_Event_Graphics-13-450x254-1.jpg
END:VEVENT
END:VCALENDAR